It was found that the TGF-β1/Smad3 pathway was activated in hepatoma model, suggesting that the TGF-β1/Smad3 pathway played a significant role in the development of liver cancer [14]. The gene discussed is SMAD3; the disease is hepatocellular carcinoma.